140 related articles for article (PubMed ID: 17463174)
21. Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not.
Sombogaard F; Peeters AM; Baan CC; Mathot RA; Quaedackers ME; Vulto AG; Weimar W; van Gelder T
Ther Drug Monit; 2009 Oct; 31(5):549-56. PubMed ID: 19704402
[TBL] [Abstract][Full Text] [Related]
22. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.
Dang W; Yin Y; Wang Y; Wang W; Su J; Sprengers D; van der Laan LJW; Felczak K; Pankiewicz KW; Chang KO; Koopmans MPG; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807916
[TBL] [Abstract][Full Text] [Related]
25. Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ozono S; Kagawa Y; Kawakami J
Clin Chim Acta; 2009 Nov; 409(1-2):56-61. PubMed ID: 19723513
[TBL] [Abstract][Full Text] [Related]
26. Inosine 5'-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients.
Glander P; Waiser J; Hambach P; Bachmann F; Budde K; Eckardt KU; Friedersdorff F; Gaedeke J; Kron S; Lorkowski C; Mai M; Neumayer HH; Peters R; Rudolph B; Schmidt D; Wu K; Liefeldt L
Transplantation; 2021 Apr; 105(4):916-927. PubMed ID: 32496356
[TBL] [Abstract][Full Text] [Related]
27. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
[TBL] [Abstract][Full Text] [Related]
28. Influence of mycophenolic acid on inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells.
Daxecker H; Raab M; Müller MM
Clin Chim Acta; 2002 Apr; 318(1-2):71-7. PubMed ID: 11880114
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model.
Langman LJ; Shapiro AM; Lakey JR; LeGatt DF; Kneteman NM; Yatscoff RW
Transplantation; 1996 Jan; 61(1):87-92. PubMed ID: 8560580
[TBL] [Abstract][Full Text] [Related]
30. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
31. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.
Glander P; Hambach P; Braun KP; Fritsche L; Waiser J; Mai I; Neumayer HH; Budde K
Int J Clin Pharmacol Ther; 2003 Oct; 41(10):470-6. PubMed ID: 14703953
[TBL] [Abstract][Full Text] [Related]
32. Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells.
Glander P; Sombogaard F; Budde K; van Gelder T; Hambach P; Liefeldt L; Lorkowski C; Mai M; Neumayer HH; Vulto AG; Mathot RA
Ther Drug Monit; 2009 Jun; 31(3):351-9. PubMed ID: 19333146
[TBL] [Abstract][Full Text] [Related]
33. High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.
Schaier M; Scholl C; Scharpf D; Schmitt WH; Schwenger V; Zeier M; Sommerer C
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i138-45. PubMed ID: 25805745
[TBL] [Abstract][Full Text] [Related]
34. Expression of IMPDH mRNA after mycophenolate administration in male volunteers.
Kim S; Lee W; Chun S; Um TH; Min WK
Biomed Res Int; 2014; 2014():870209. PubMed ID: 25105143
[TBL] [Abstract][Full Text] [Related]
35. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
Mino Y; Naito T; Shimoyama K; Ogawa N; Kawakami J
Ann Clin Biochem; 2017 Jul; 54(4):490-494. PubMed ID: 27538768
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
Goldsmith D; Carrey EA; Edbury S; Smolenski RT; Jagodzinski P; Simmonds HA
Clin Sci (Lond); 2004 Jul; 107(1):63-8. PubMed ID: 14723604
[TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamic Monitoring of Mycophenolic Acid Therapy: Improved Liquid Chromatography-Tandem Mass Spectrometry Method for Measuring Inosin-5'-Monophosphate Dehydrogenase Activity.
Weißbarth G; Wiesen MHJ; Fietz C; Streichert T; Ehren R; Weber LT; Müller C
Ther Drug Monit; 2020 Apr; 42(2):282-288. PubMed ID: 31425491
[TBL] [Abstract][Full Text] [Related]
38. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
[TBL] [Abstract][Full Text] [Related]
39. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
[TBL] [Abstract][Full Text] [Related]
40. Inosine monophosphate dehydrogenase expression and activity are significantly lower in kidney transplant recipients with diabetes mellitus.
Dostalek M; Gohh RY; Akhlaghi F
Ther Drug Monit; 2013 Jun; 35(3):374-83. PubMed ID: 23666569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]